mRNA COVID vaccines enhance cancer treatment outcomes and survival
A study by the University of Texas MD Anderson and the University of Florida found that mRNA COVID-19 vaccines not only protect against the virus but also nearly double the median survival time of cancer patients by boosting the immune system.
